Moderna MRNA is expected to report first-quarter 2025 earnings on May 1, before the opening bell. The company’s earnings beat ...

In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an ...

Moderna faces challenges with respiratory vaccine sales and strong competition. Click here to read an analysis of MRNA stock ...

Moderna could have many products on the market and in a variety of areas. Among these, we may find a cytomegalovirus (CMV) vaccine, a personalized cancer vaccine, and a norovirus vaccine.

such as lyme and norovirus vaccines. Receive News & Ratings for Moderna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ...

and norovirus – respectively in and close to phase 3 testing – along with two therapies for rare diseases methylmalonic acidaemia (MMA) and propionic acidaemia (PA) in phase 1/2 and Moderna's ...

A norovirus warning has been issued by the NHS across an area of Scotland, and people have been warned not to visit hospitals if they are experiencing any symptoms of the nasty vomiting bug.

NHS Borders has urged people not to visit loved ones in hospital amid an increase in the number of patients with norovirus. Norovirus is a stomach bug that causes vomiting and diarrhoeaCredit ...

A norovirus outbreak has sickened 140 people at Hotel Daiheigen, a hot spring resort in Japan's Hokkaido, local media reported Saturday. The source of the outbreak was identified as food prepared ...